PCV10在巴布亚新几内亚儿童中诱导蛋白D IgG应答但两年内对不可分型流感嗜血杆菌携带无影响
研究纳入101名巴布亚新几内亚儿童,随机接种PCV10或PCV13,在1、4、9、10、23、24月龄采集血清和鼻咽拭子。PCV10在4月龄时提高蛋白D IgG水平,但两组约95%儿童在4月龄已携带不可分型流感嗜血杆菌,且PCV10对携带密度无影响。结论:PCV10诱导蛋白D抗体应答但未影响不可分型流感嗜血杆菌携带。
要点
- PCV10在4月龄时提高蛋白D IgG水平,但未减少NTHi携带。
- 两组儿童4月龄时NTHi携带率均约95%,PCV10对携带密度无影响。
- 早期PCV10接种诱导的蛋白D抗体应答不足以控制NTHi定植。
核心结论
- PCV10早期接种可诱导稳健的蛋白D抗体应答,但对不可分型流感嗜血杆菌携带无影响。
研究设计与样本
- 研究纳入101名巴布亚新几内亚儿童,PCV10组55名、PCV13组46名,在1、2、3月龄接种,于1、4、9、10、23、24月龄采集血清和鼻咽拭子。
主要发现
- 巴布亚新几内亚儿童自然产生蛋白D IgG抗体,PCV10接种组在4月龄时抗体水平升高。
- 无论接种PCV10还是PCV13,大多数儿童在4月龄时已携带NTHi(约95%)。
- PCV10对NTHi携带密度无影响。
临床怎么用
- 在NTHi携带早且密集的人群中,PCV10诱导的蛋白D抗体应答未转化为对NTHi携带的减少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nasopharyngeal colonisation with nontypeable Haemophilus influenzae (NTHi) is associated with development of infections including pneumonia and otitis media. The 10-valent pneumococcal conjugate vaccine (PCV10) uses NTHi Protein D (PD) as a carrier. Papua New Guinean children have exceptionally early and dense NTHi carriage, and high rates of NTHi-associated disease. Vaccination with PCV10 could potentially reduce NTHi carriage and disease in this population by inducing a NTHi PD immune response. METHODS: Serum and nasopharyngeal swabs were collected from 101 Papua New Guinean children at 1, 4, 9, 10, 23 and 24 months of age. Children received PCV10 (n = 55) or PCV13 (not containing NTHi PD) (n = 46) at 1, 2 and 3 months of age. NTHi carriage density was measured in swabs by qPCR. Serum PD-IgG levels were measured by bead-based immunoassay. RESULTS: Papua New Guinean children did naturally develop PD-IgG antibodies whose levels were increased at 4 months of age with PCV10 vaccination at 1-2-3 months. Despite this, most children were colonised with NTHi by 4 months of age (~95%) regardless of being vaccinated with PCV10 or PCV13, and PCV10 had no impact on NTHi carriage density. CONCLUSION: Early vaccination of infants with PCV10 elicited a robust PD antibody response but this had no impact on NTHi carriage. TRIAL REGISTRATION: ClinicalTrials.gov CTN NCT01619462.
引用
- Rahman T, de Gier C, Orami T, et al. PCV10 elicits Protein D IgG responses in Papua New Guinean children but has no impact on NTHi carriage in the first two years of life. Vaccine. 2021. PMID: 34024658. doi:10.1016/j.vaccine.2021.05.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。